Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Germline TERT promoter mutations are rare in familial melanoma

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Selection criteria for assembling a pediatric cancer predisposition syndrome gene panel

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Two cases of somatic STK11 mosaicism in Danish patients with Peutz-Jeghers syndrome

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. BRCA1/BRCA2 founder mutations and cancer risks: impact in the western Danish population

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. High accuracy of family history of melanoma in Danish melanoma cases

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Danish guidelines for management of non-APC-associated hereditary polyposis syndromes

    Research output: Contribution to journalReviewResearchpeer-review

  2. Selection criteria for assembling a pediatric cancer predisposition syndrome gene panel

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Mark Harland
  • Mia Petljak
  • Carla Daniela Robles-Espinoza
  • Zhihao Ding
  • Nelleke A Gruis
  • Remco van Doorn
  • Karen A Pooley
  • Alison M Dunning
  • Lauren G Aoude
  • Karin A W Wadt
  • Anne-Marie Gerdes
  • Kevin M Brown
  • Nicholas K Hayward
  • Julia A Newton-Bishop
  • David J Adams
  • D Timothy Bishop
View graph of relations

Germline CDKN2A mutations occur in 40 % of 3-or-more case melanoma families while mutations of CDK4, BAP1, and genes involved in telomere function (ACD, TERF2IP, POT1), have also been implicated in melanomagenesis. Mutation of the promoter of the telomerase reverse transcriptase (TERT) gene (c.-57 T>G variant) has been reported in one family. We tested for the TERT promoter variant in 675 multicase families wild-type for the known high penetrance familial melanoma genes, 1863 UK population-based melanoma cases and 529 controls. Germline lymphocyte telomere length was estimated in carriers. The c.-57 T>G TERT promoter variant was identified in one 7-case family with multiple primaries and early age of onset (earliest, 15 years) but not among population cases or controls. One family member had multiple primary melanomas, basal cell carcinomas and a bladder tumour. The blood leukocyte telomere length of a carrier was similar to wild-type cases. We provide evidence confirming that a rare promoter variant of TERT (c.-57 T>G) is associated with high penetrance, early onset melanoma and potentially other cancers, and explains <1 % of UK melanoma multicase families. The identification of POT1 and TERT germline mutations highlights the importance of telomere integrity in melanoma biology.

Original languageEnglish
JournalFamilial Cancer
Volume15
Issue number1
Pages (from-to)139-40
ISSN1389-9600
DOIs
Publication statusPublished - 2016

ID: 45842748